Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 296

    1.

    The preventive phase I trial with the HIV-1 Tat-based vaccine.

    Ensoli B, Fiorelli V, Ensoli F, Lazzarin A, Visintini R, Narciso P, Di Carlo A, Tripiciano A, Longo O, Bellino S, Francavilla V, Paniccia G, Arancio A, Scoglio A, Collacchi B, Ruiz Alvarez MJ, Tambussi G, Tassan Din C, Palamara G, Latini A, Antinori A, D'Offizi G, Giuliani M, Giulianelli M, Carta M, Monini P, Magnani M, Garaci E.

    Vaccine. 2009 Dec 11;28(2):371-8. Epub 2009 Oct 29.PMID: 19879233 [PubMed - in process]Related articles

    2.

    Insights into reasons for discontinuation according to year of starting first regimen of highly active antiretroviral therapy in a cohort of antiretroviral-naïve patients.

    Cicconi P, Cozzi-Lepri A, Castagna A, Trecarichi EM, Antinori A, Gatti F, Cassola G, Sighinolfi L, Castelli P, d'Arminio Monforte A; for the ICoNA Foundation Study Group.

    HIV Med. 2009 Aug 31. [Epub ahead of print]PMID: 19732176 [PubMed - as supplied by publisher]Related articles

    3.

    Changes in cognition during antiretroviral therapy: comparison of 2 different ranking systems to measure antiretroviral drug efficacy on HIV-associated neurocognitive disorders.

    Tozzi V, Balestra P, Salvatori MF, Vlassi C, Liuzzi G, Giancola ML, Giulianelli M, Narciso P, Antinori A.

    J Acquir Immune Defic Syndr. 2009 Sep 1;52(1):56-63. Erratum in: J Acquir Immune Defic Syndr. 2009 Dec 1;52(4):529. PMID: 19731418 [PubMed - indexed for MEDLINE]Related articles

    4.

    Risk of developing specific AIDS-defining illnesses in patients coinfected with HIV and hepatitis C virus with or without liver cirrhosis.

    d'Arminio Monforte A, Cozzi-Lepri A, Castagna A, Antinori A, De Luca A, Mussini C, Caputo SL, Arlotti M, Magnani G, Pellizzer G, Maggiolo F, Puoti M; Icona Foundation Study Group.

    Clin Infect Dis. 2009 Aug 15;49(4):612-22.PMID: 19591597 [PubMed - indexed for MEDLINE]Related articles

    5.

    MUC2 but not MUC5 expression correlates with prognosis in radically resected pancreatic cancer patients.

    Pantano F, Baldi A, Santini D, Vincenzi B, Borzomati D, Vecchio FM, Castri F, Antinori A, Caraglia M, Magistrelli P, Coppola R, Tonini G.

    Cancer Biol Ther. 2009 Jun;8(11):996-9.PMID: 19587537 [PubMed - indexed for MEDLINE]Related articles

    6.

    Italian consensus statement on management of HIV-infected individuals with advanced disease naïve to antiretroviral therapy.

    Antinori A, Ammassari A, Torti C, Marconi P, Andreoni M, Angarano G, Bonora S, Castagna A, Cauda R, Clerici M, Monforte A, De Luca A, Di Perri G, Galli M, Girardi E, Gori A, Lazzarin A, Lo Caputo S, Mazzotta F, Montella F, Mussini C, Perno CF, Puoti M, Rizzardini G, Rusconi S, Vullo V, Carosi G.

    Infection. 2009 Jun;37(3):270-82. Epub 2009 May 28.PMID: 19479193 [PubMed - indexed for MEDLINE]Related articles

    7.

    Increasing clinical virulence in two decades of the Italian HIV epidemic.

    Müller V, Maggiolo F, Suter F, Ladisa N, De Luca A, Antinori A, Sighinolfi L, Quiros-Roldan E, Carosi G, Torti C.

    PLoS Pathog. 2009 May;5(5):e1000454. Epub 2009 May 29.PMID: 19478880 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.

    Torti C, Lapadula G, Antinori A, Quirino T, Maserati R, Castelnuovo F, Maggiolo F, De Luca A, Paraninfo G, Antonucci F, Migliorino G, Lazzarin A, Di Perri G, Rizzardini G, Esposito R, Carosi G.

    Infection. 2009 Jun;37(3):244-9. Epub 2009 May 26.PMID: 19471856 [PubMed - indexed for MEDLINE]Related articles

    9.

    Historical resistance profile helps to predict salvage failure.

    Zaccarelli M, Lorenzini P, Ceccherini-Silberstein F, Tozzi V, Forbici F, Gori C, Trotta MP, Boumis E, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of HIV Genotype Resistance Test.

    Antivir Ther. 2009;14(2):285-91.PMID: 19430103 [PubMed - indexed for MEDLINE]Related articles

    10.

    External Beam Radiotherapy Plus 24-Hour Continuous Infusion of Gemcitabine in Unresectable Pancreatic Carcinoma: Long-Term Results of a Phase II Study.

    Mattiucci GC, Morganti AG, Valentini V, Ippolito E, Alfieri S, Antinori A, Crucitti A, D'Agostino GR, Di Lullo L, Luzi S, Mantini G, Smaniotto D, Doglietto GB, Cellini N.

    Int J Radiat Oncol Biol Phys. 2009 May 8. [Epub ahead of print]PMID: 19427747 [PubMed - as supplied by publisher]Related articles

    11.

    Russell body gastritis associated with Helicobacter pylori infection in an HIV-positive patient: case report and review of the literature.

    Licci S, Sette P, Del Nonno F, Ciarletti S, Antinori A, Morelli L.

    Z Gastroenterol. 2009 Apr;47(4):357-60. Epub 2009 Apr 8.PMID: 19358062 [PubMed - indexed for MEDLINE]Related articles

    12.

    [Immediate and long-term results after laparoscopic primary ventral hernia repair]

    Antinori A, Moschella F, Maci E, Accetta C, Nunziata J, Magistrelli P.

    Ann Ital Chir. 2008 Nov-Dec;79(6):435-9. Italian. PMID: 19354038 [PubMed - indexed for MEDLINE]Related articles

    13.

    Characterization and structural analysis of HIV-1 integrase conservation.

    Ceccherini-Silberstein F, Malet I, D'Arrigo R, Antinori A, Marcelin AG, Perno CF.

    AIDS Rev. 2009 Jan-Mar;11(1):17-29. Review.PMID: 19290031 [PubMed - indexed for MEDLINE]Related articles

    14.

    Effect of suppressing HIV viremia on the HIV progression of patients undergoing a genotype resistance test after treatment failure.

    Zaccarelli M, Lorenzini P, Tozzi V, Forbici F, Ceccherini-Silberstein F, Gori C, D'Arrigo R, Trotta MP, Narciso P, Perno CF, Antinori A; Collaborative Group for Clinical Use of the HIV Genotype Resistance Test (GRT) at the National Institute for Infectious Diseases "Lazzaro Spallanzani".

    Infection. 2009 Jun;37(3):203-9. Epub 2009 Mar 9.PMID: 19274429 [PubMed - indexed for MEDLINE]Related articles

    15.

    Phase I therapeutic trial of the HIV-1 Tat protein and long term follow-up.

    Longo O, Tripiciano A, Fiorelli V, Bellino S, Scoglio A, Collacchi B, Alvarez MJ, Francavilla V, Arancio A, Paniccia G, Lazzarin A, Tambussi G, Din CT, Visintini R, Narciso P, Antinori A, D'Offizi G, Giulianelli M, Carta M, Di Carlo A, Palamara G, Giuliani M, Laguardia ME, Monini P, Magnani M, Ensoli F, Ensoli B.

    Vaccine. 2009 May 26;27(25-26):3306-12. Epub 2009 Feb 7.PMID: 19208456 [PubMed - indexed for MEDLINE]Related articles

    16.

    Dynamics of NRTI resistance mutations during therapy interruption.

    Trignetti M, Sing T, Svicher V, Santoro MM, Forbici F, D'arrigo R, Bellocchi MC, Santoro M, Marconi P, Zaccarelli M, Trotta MP, Bellagamba R, Narciso P, Antinori A, Lengauer T, Perno CF, Ceccherini-Silberstein F.

    AIDS Res Hum Retroviruses. 2009 Jan;25(1):57-64.PMID: 19182921 [PubMed - indexed for MEDLINE]Related articles

    17.

    Two different patterns of mutations are involved in the genotypic resistance score for atazanavir boosted versus unboosted by ritonavir in multiple failing patients.

    Santoro MM, Bertoli A, Lorenzini P, Ceccherini-Silberstein F, Gianotti N, Mussini C, Torti C, Di Perri G, Barbarini G, Bini T, Melzi S, Caramello P, Maserati R, Narciso P, Micheli V, Antinori A, Perno CF; CARe Study Group.

    Infection. 2009 Jun;37(3):233-43. Epub 2009 Jan 23.PMID: 19169632 [PubMed - indexed for MEDLINE]Related articles

    18.

    Treatment with the fusion inhibitor enfuvirtide influences the appearance of mutations in the human immunodeficiency virus type 1 regulatory protein rev.

    Svicher V, Alteri C, D'Arrigo R, Laganà A, Trignetti M, Lo Caputo S, Callegaro AP, Maggiolo F, Mazzotta F, Ferro A, Dimonte S, Aquaro S, di Perri G, Bonora S, Tommasi C, Trotta MP, Narciso P, Antinori A, Perno CF, Ceccherini-Silberstein F.

    Antimicrob Agents Chemother. 2009 Jul;53(7):2816-23. Epub 2009 Jan 5.PMID: 19124665 [PubMed - indexed for MEDLINE]Related articles

    19.

    Patients presenting with AIDS in the HAART era: a collaborative cohort analysis.

    Mussini C, Manzardo C, Johnson M, Monforte A, Uberti-Foppa C, Antinori A, Gill MJ, Sighinolfi L, Borghi V, Lazzarin A, Miró JM, Sabin C; Late Presenter Investigators.

    AIDS. 2008 Nov 30;22(18):2461-9.PMID: 19005269 [PubMed - indexed for MEDLINE]Related articles

    20.

    Recruitment criteria for acute disseminated encephalomyelitis studies: the need for consensus.

    Marchioni E, Bono G, Tavazzi E, Antinori A, Minoli L, Ceroni M; Italian Postinfectious Demyelinating Diseases (IPoDD) Study Group; Italian Study Group of Neuroinfectious Diseases.

    Neurol Sci. 2008 Sep;29(4):203-4. No abstract available. PMID: 18810592 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis.

    De Luca A, Ammassari A, Pezzotti P, Cinque P, Gasnault J, Berenguer J, Di Giambenedetto S, Cingolani A, Taoufik Y, Miralles P, Marra CM, Antinori A; Gesida 9/99, IRINA, ACTG 363 Study Groups.

    AIDS. 2008 Sep 12;22(14):1759-67.PMID: 18753934 [PubMed - indexed for MEDLINE]Related articles

    22.

    [Laparoscopic repair of incisional and ventral hernia]

    Antinori A, Moschella F, Tomaiuolo PM, Crucitti A, La Greca A, Maci E, Magistrelli P.

    Chir Ital. 2008 May-Jun;60(3):409-17. Italian. PMID: 18709780 [PubMed - indexed for MEDLINE]Related articles

    23.

    Promyelocytic leukemia (PML) gene expression is a prognostic factor in ampullary cancer patients.

    Vincenzi B, Santini D, Perrone G, Russo A, Adamo V, Rizzo S, Castri F, Antinori A, Alloni R, Crucitti PF, Morini S, Rabitti C, Vecchio FM, Magistrelli P, Coppola R, Tonini G.

    Ann Oncol. 2009 Jan;20(1):78-83. Epub 2008 Aug 9.PMID: 18689862 [PubMed - indexed for MEDLINE]Related articles

    24.

    Plasma HIV RNA decline and emergence of drug resistance mutations among patients with multiple virologic failures receiving resistance testing-guided HAART.

    Tozzi V, Bellagamba R, Castiglione F, Amendola A, Ivanovic J, Nicastri E, Libertone R, D'Offizi G, Liuzzi G, Gori C, Forbici F, D'Arrigo R, Bertoli A, Salvatori MF, Capobianchi MR, Antinori A, Perno CF, Narciso P.

    AIDS Res Hum Retroviruses. 2008 Jun;24(6):787-96.PMID: 18507523 [PubMed - indexed for MEDLINE]Related articles

    25.

    Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort study.

    Sighinolfi L, Torti C, Zeni C, Ghinelli F, Suter F, Maggiolo F, Antinori A, Antonucci G, Castelnuovo F, Ladisa N, Migliorino M, Novati S, De Luca A, Lo Caputo S, Paraninfo G, Tinelli C, Carosi G; Italian MASTER Database Cohort.

    Infection. 2008 Jun;36(3):244-9. Epub 2008 May 3.PMID: 18454340 [PubMed - indexed for MEDLINE]Related articles

    26.

    Self-reported sexual dysfunction is frequent among HIV-infected persons and is associated with suboptimal adherence to antiretrovirals.

    Trotta MP, Ammassari A, Murri R, Marconi P, Zaccarelli M, Cozzi-Lepri A, Acinapura R, Abrescia N, De Longis P, Tozzi V, Scalzini A, Vullo V, Boumis E, Nasta P, Monforte A, Antinori A; AdICoNA and AdeSpall Study Group.

    AIDS Patient Care STDS. 2008 Apr;22(4):291-9.PMID: 18422461 [PubMed - indexed for MEDLINE]Related articles

    27.

    Specific enfuvirtide-associated mutational pathways in HIV-1 Gp41 are significantly correlated with an increase in CD4(+) cell count, despite virological failure.

    Svicher V, Aquaro S, D'Arrigo R, Artese A, Dimonte S, Alcaro S, Santoro MM, Di Perri G, Caputo SL, Bellagamba R, Zaccarelli M, Visco-Comandini U, Antinori A, Narciso P, Ceccherini-Silberstein F, Perno CF.

    J Infect Dis. 2008 May 15;197(10):1408-18.PMID: 18419549 [PubMed - indexed for MEDLINE]Related articles

    28.

    Progressive multifocal leukoencephalopathy in HIV-infected patients in the era of HAART: radiological features at diagnosis and follow-up and correlation with clinical variables.

    Giancola ML, Rizzi EB, Lorenzini P, Rovighi L, Baldini F, Schininà V, Larussa D, Bibbolino C, Antinori A.

    AIDS Res Hum Retroviruses. 2008 Feb;24(2):155-62.PMID: 18240958 [PubMed - indexed for MEDLINE]Related articles

    29.

    Virological response to salvage therapy in HIV-infected persons carrying the reverse transcriptase K65R mutation.

    Antinori A, Trotta MP, Lorenzini P, Torti C, Gianotti N, Maggiolo F, Ceccherini-Silberstein F, Nasto P, Castagna A, De Luca A, Mussini C, Andreoni M, Perno CF; GNOMO Study Group.

    Antivir Ther. 2007;12(8):1175-83.PMID: 18240858 [PubMed - indexed for MEDLINE]Related articles

    30.

    Human equilibrative nucleoside transporter 1 (hENT1) protein is associated with short survival in resected ampullary cancer.

    Santini D, Perrone G, Vincenzi B, Lai R, Cass C, Alloni R, Rabitti C, Antinori A, Vecchio F, Morini S, Magistrelli P, Coppola R, Mackey JR, Tonini G.

    Ann Oncol. 2008 Apr;19(4):724-8. Epub 2008 Jan 10.PMID: 18187485 [PubMed - indexed for MEDLINE]Related articlesFree article

    31.

    Viro-immunologic response to ritonavir-boosted or unboosted atazanavir in a large cohort of multiply treated patients: the CARe Study.

    Santoro MM, Bertoli A, Lorenzini P, Lazzarin A, Esposito R, Carosi G, Di Perri G, Filice G, Moroni M, Rizzardini G, Caramello P, Maserati R, Narciso P, Cargnel A, Antinori A, Perno CF; CARe Study Group.

    AIDS Patient Care STDS. 2008 Jan;22(1):7-16.PMID: 18095835 [PubMed - indexed for MEDLINE]Related articles

    32.

    T cell selection and differentiation in AIDS disease: the model of HIV-discordant monozygotic twins.

    Agrati C, Gioia C, Soldani F, Martini F, Antinori A, Poccia F.

    J Biol Regul Homeost Agents. 2006 Jan-Jun;20(1-2):24-8.PMID: 18088551 [PubMed - indexed for MEDLINE]Related articles

    33.

    Observational study on HIV-infected subjects failing HAART receiving tenofovir plus didanosine as NRTI backbone.

    Bongiovanni M, Gianotti N, Chiesa E, Nasta P, Cicconi P, Capetti A, di Biagio A, Matti A, Tirelli V, Marconi P, de Luca A, Mussini C, Gatti F, Zaccarelli M, Abeli C, Torti C, Antinori A, Castagna A, d'Arminio Monforte A.

    Infection. 2007 Dec;35(6):451-6. Epub 2007 Nov 21.PMID: 18034204 [PubMed - indexed for MEDLINE]Related articles

    34.

    Improved interpretation of genotypic changes in the HIV-1 reverse transcriptase coding region that determine the virological response to didanosine.

    De Luca A, Giambenedetto SD, Trotta MP, Colafigli M, Prosperi M, Ruiz L, Baxter J, Clevenbergh P, Cauda R, Perno CF, Antinori A.

    J Infect Dis. 2007 Dec 1;196(11):1645-53. Epub 2007 Oct 26.PMID: 18008248 [PubMed - indexed for MEDLINE]Related articles

    35.

    Evidence of dual sexual transmission of multi-resistant HIV with two years persistence of resistance to NRTI and NNRTI: a case report.

    Zaccarelli M, Marconi P, Visco-Comandini U, Liuzzi G, Sette P, Acinapura R, Mosti S, Ammassari A, Perno CF, Antinori A.

    Infection. 2008 Mar;36(2):178-80. Epub 2007 Oct 25.PMID: 17962906 [PubMed - indexed for MEDLINE]Related articles

    36.

    gp41 sequence variability in HIV type 1 non-B subtypes infected patients undergoing enfuvirtide pressure.

    D'Arrigo R, Ciccozzi M, Gori C, Montieri S, Aquaro S, Bellagamba R, Boumis E, Di Perri G, Pizzi D, Antinori A, Rezza G, Perno CF.

    AIDS Res Hum Retroviruses. 2007 Oct;23(10):1296-302.PMID: 17961119 [PubMed - indexed for MEDLINE]Related articles

    37.

    Updated research nosology for HIV-associated neurocognitive disorders.

    Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE.

    Neurology. 2007 Oct 30;69(18):1789-99. Epub 2007 Oct 3.PMID: 17914061 [PubMed - indexed for MEDLINE]Related articles

    38.

    Optimal timing and best antiretroviral regimen in treatment-naive HIV-infected individuals with advanced disease.

    Manzardo C, Zaccarelli M, Agüero F, Antinori A, Miró JM.

    J Acquir Immune Defic Syndr. 2007 Sep;46 Suppl 1:S9-18. Review.PMID: 17713424 [PubMed - indexed for MEDLINE]Related articles

    39.

    Changes in the incidence and predictors of human immunodeficiency virus-associated dementia in the era of highly active antiretroviral therapy.

    Bhaskaran K, Mussini C, Antinori A, Walker AS, Dorrucci M, Sabin C, Phillips A, Porter K; CASCADE Collaboration.

    Ann Neurol. 2008 Feb;63(2):213-21.PMID: 17894380 [PubMed - indexed for MEDLINE]Related articles

    40.

    Mucin 2 (MUC2) and mucin 5 (MUC5) expression is not associated with prognosis in patients with radically resected ampullary carcinoma.

    Santini D, Baldi A, Vincenzi B, Mellone P, Campioni M, Antinori A, Borzomati D, Coppola R, Magistrelli P, Tonini G.

    J Clin Pathol. 2007 Sep;60(9):1069-70. No abstract available. PMID: 17761747 [PubMed - indexed for MEDLINE]Related articles

    41.

    Characterization and structural analysis of novel mutations in human immunodeficiency virus type 1 reverse transcriptase involved in the regulation of resistance to nonnucleoside inhibitors.

    Ceccherini-Silberstein F, Svicher V, Sing T, Artese A, Santoro MM, Forbici F, Bertoli A, Alcaro S, Palamara G, d'Arminio Monforte A, Balzarini J, Antinori A, Lengauer T, Perno CF.

    J Virol. 2007 Oct;81(20):11507-19. Epub 2007 Aug 8.PMID: 17686836 [PubMed - indexed for MEDLINE]Related articlesFree article

    42.

    Is the CD4 cell percentage a better marker of immunosuppression than the absolute CD4 cell count in HIV-infected patients with cirrhosis?

    Bongiovanni M, Gori A, Lepri AC, Antinori A, de Luca A, Pagano G, Chiodera A, Puoti M, Monforte A; Italian Cohort of Antiretroviral-Naive Patients Study Group.

    Clin Infect Dis. 2007 Sep 1;45(5):650-3. Epub 2007 Aug 1.PMID: 17683003 [PubMed - indexed for MEDLINE]Related articles

    43.

    Meckel's diverticulum findings on Tc-99m red blood cell scintigraphy in a bleeding leukemic patient confirmed by Tc-99m pertechnetate scintigraphy.

    Ciccoritti L, Valenza V, Pierconti F, Di Giuda D, D'Errico G, Antinori A, Crucitti A.

    Clin Nucl Med. 2007 Aug;32(8):668-70.PMID: 17667451 [PubMed - indexed for MEDLINE]Related articles

    44.

    First Italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006).

    Carosi G, Quiros-Roldan E, Torti C, Antinori A, Bevilacqua M, Bonadonna RC, Bonfanti P, Castagna A, Cauda R, d'Arminio-Monforte A, Di Gregorio P, Di Perri G, Esposito R, Fatuzzo F, Gervasoni C, Giannattasio C, Guaraldi G, Lazzarin A, Lo Caputo S, Maggi P, Mazzotta F, Moroni M, Prestileo T, Ranieri R, Rizzardini G, Russo R, Galli M; Members of the Italian Cardiovascular Risk Guidelines Working Group.

    Infection. 2007 Jun;35(3):134-42.PMID: 17565453 [PubMed - indexed for MEDLINE]Related articles

    45.

    The V118I mutation as a marker of advanced HIV infection and disease progression.

    Zaccarelli M, Tozzi V, Lorenzini P, Forbici F, Narciso P, Ceccherini-Silberstein F, Trotta MP, Bertoli A, Liuzzi G, Marconi P, Mosti S, Perno CF, Antinori A.

    Antivir Ther. 2007;12(2):163-8.PMID: 17503658 [PubMed - indexed for MEDLINE]Related articles

    46.

    CD4+ T cell evolution and predictors of its trend before and after tenofovir/didanosine backbone in the presence of sustained undetectable HIV plasma viral load.

    Torti C, Lapadula G, Barreiro P, Soriano V, Mandalia S, De Silvestri A, Suter F, Maggiolo F, Antinori A, Antonucci F, Maserati R, El Hamad I, Pierotti P, Sighinolfi L, Migliorino G, Ladisa N, Carosi G; Italian MASTER Cohort.

    J Antimicrob Chemother. 2007 Jun;59(6):1141-7. Epub 2007 Apr 13.PMID: 17434879 [PubMed - indexed for MEDLINE]Related articlesFree article

    47.

    Sexual dysfunction in HIV infection.

    Trotta MP, Ammassari A, Murri R, Monforte A, Antinori A.

    Lancet. 2007 Mar 17;369(9565):905-6. No abstract available. PMID: 17368150 [PubMed - indexed for MEDLINE]Related articles

    48.

    Persistence of neuropsychologic deficits despite long-term highly active antiretroviral therapy in patients with HIV-related neurocognitive impairment: prevalence and risk factors.

    Tozzi V, Balestra P, Bellagamba R, Corpolongo A, Salvatori MF, Visco-Comandini U, Vlassi C, Giulianelli M, Galgani S, Antinori A, Narciso P.

    J Acquir Immune Defic Syndr. 2007 Jun 1;45(2):174-82.PMID: 17356465 [PubMed - indexed for MEDLINE]Related articles

    49.

    The effect of HIV-1 resistance mutations after first-line virological failure on the possibility to sequence antiretroviral drugs in second-line regimens.

    Maggiolo F, Ripamonti D, Torti C, Arici C, Antinori A, Quiros-Roldan E, Minoli L, Sighinolfi L, Nasta P, Suter F; MASTER Data Base Cohort.

    Antivir Ther. 2006;11(7):923-9.PMID: 17302255 [PubMed - indexed for MEDLINE]Related articles

    50.

    Effectiveness of a multi-disciplinary standardized management model in the treatment of chronic hepatitis C in drug addicts engaged in detoxification programmes.

    Guadagnino V, Trotta MP, Montesano F, Babudieri S, Caroleo B, Armignacco O, Carioti J, Maio G, Monarca R, Antinori A; Nocchiero Study Group.

    Addiction. 2007 Mar;102(3):423-31.PMID: 17298650 [PubMed - indexed for MEDLINE]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Search details

    » See more...